Medicine Man Technologies Inc has a consensus price target of $2.5 based on the ratings of 1 analysts. The high is $2.5 issued by Benchmark on May 16, 2024. The low is $2.5 issued by Benchmark on May 16, 2024. The 3 most-recent analyst ratings were released by Benchmark on May 16, 2024, March 28, 2024, and March 30, 2023, respectively. With an average price target of $2.67 between Benchmark, there's an implied 788.89% upside for Medicine Man Technologies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/16/2024 | Buy Now | 733.33% | Benchmark | Mike Hickey | → $2.5 | Reiterates | Buy → Buy | Get Alert |
03/28/2024 | Buy Now | 733.33% | Benchmark | Mike Hickey | $3 → $2.5 | Maintains | Buy | Get Alert |
03/30/2023 | Buy Now | 900% | Benchmark | Mike Hickey | → $3 | Reiterates | → Buy | Get Alert |
12/14/2021 | Buy Now | 1233.33% | Benchmark | Mike Hickey | — | Initiates | → Buy | Get Alert |
The latest price target for Medicine Man Technologies (OTCEM:SHWZ) was reported by Benchmark on May 16, 2024. The analyst firm set a price target for $2.50 expecting SHWZ to rise to within 12 months (a possible 733.33% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Medicine Man Technologies (OTCEM:SHWZ) was provided by Benchmark, and Medicine Man Technologies reiterated their buy rating.
There is no last upgrade for Medicine Man Technologies
There is no last downgrade for Medicine Man Technologies.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicine Man Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicine Man Technologies was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
While ratings are subjective and will change, the latest Medicine Man Technologies (SHWZ) rating was a reiterated with a price target of $2.50 to $2.50. The current price Medicine Man Technologies (SHWZ) is trading at is $0.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.